Trueblood Wealth Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,500
Closed -$274K 272
2026
Q1
$274K Buy
2,500
+1,250
+100% +$178K 0.11% 215
2025
Q4
$208K Buy
+1,250
New +$209K 0.08% 243
2025
Q3
Sell
-2,500
Closed -$226K 261
2025
Q2
$226K Buy
+2,500
New +$198K 0.09% 225
2025
Q1
Sell
-2,500
Closed -$331K 243
2024
Q4
$331K Buy
+2,500
New +$235K 0.16% 172

Other funds holding ALAB

Trueblood Wealth Management's ALAB Position: Q2 2026 in Review

Trueblood Wealth Management sold out of Astera Labs (ALAB) in Q2 2026, closing a stake of 2,500 shares — an estimated $274K sold.

Trueblood Wealth Management first reported a position in ALAB in Q4 2024 and held it in 4 quarters. The position peaked at $331K in Q4 2024. 989 funds tracked by Wall St. Rank hold ALAB as of Q2 2026.

  • Trueblood Wealth Management reported no remaining Astera Labs position as of Q2 2026 after selling out during the quarter.
  • Trueblood Wealth Management sold 2,500 Astera Labs shares in Q2 2026, an estimated $274K.
  • Trueblood Wealth Management first reported a position in Astera Labs in Q4 2024 and held it in 4 quarters.
  • Trueblood Wealth Management's Astera Labs position peaked at $331K in Q4 2024.
  • 989 funds tracked by Wall St. Rank held Astera Labs as of Q2 2026.

Based on Trueblood Wealth Management's 13F filing for Q2 2026, filed 27 Jul 2026.